Find A Physician

Return to Research and Clinical Trials Overview

More on Research and Clinical Trials

Hospital News

Return to Research and Clinical Trials Overview

More on Research and Clinical Trials

Research and Clinical Trials

Return to Research and Clinical Trials Overview

More on Research and Clinical Trials

Clinical Services

Return to Research and Clinical Trials Overview

More on Research and Clinical Trials

Weill Cornell Cancer Center

Research and Clinical Trials

Our surgeons are leading clinical research to determine which patients with small "incidental" lung cancers (those found while the patient was undergoing testing for something else) can have a limited amount of lung tissue surgically removed, rather than having a lobectomy (removal of a section of lung).

Investigators at the Weill Cornell Cancer Center are also participating in clinical research to evaluate a vaccine designed to reduce the risk of lung cancer recurrence after surgery. The vaccine targets a protein on lung cancer cells called MAGE-A3, provoking a response from the immune system against tumor cells. A similar trial is evaluating whether a daily pill (erlotinib) can reduce the risk of cancer recurrence after surgery.

Find a lung cancer clinical trial at the Weill Cornell Cancer Center.

  • Bookmark
  • Print

    Find a Doctor

Click the button above or call
1 877 NYP WELL


eNewsletters
Top of page